- Database
- February 2023
China
From €6826EUR$7,500USD£5,852GBP
- Database
- February 2023
Brazil
From €6826EUR$7,500USD£5,852GBP
- Database
- February 2023
Turkey
From €6826EUR$7,500USD£5,852GBP
- Database
- February 2023
Chile
From €6826EUR$7,500USD£5,852GBP
- Database
- February 2023
Japan
From €6826EUR$7,500USD£5,852GBP
- Database
- February 2023
Russia
From €6826EUR$7,500USD£5,852GBP
- Database
- February 2023
Sweden
From €6826EUR$7,500USD£5,852GBP
- Database
- February 2023
India
From €6826EUR$7,500USD£5,852GBP
- Database
- February 2023
Mexico
From €6826EUR$7,500USD£5,852GBP
- Database
- February 2023
Switzerland
From €6826EUR$7,500USD£5,852GBP
- Database
- February 2023
Poland
From €6826EUR$7,500USD£5,852GBP
- Database
- February 2023
Colombia
From €6826EUR$7,500USD£5,852GBP
- Database
- February 2023
Netherlands
From €6826EUR$7,500USD£5,852GBP
- Database
- February 2023
Belgium
From €6826EUR$7,500USD£5,852GBP
- Database
- February 2023
Finland
From €6826EUR$7,500USD£5,852GBP
- Report
- September 2018
- 98 Pages
North America
From €6826EUR$7,500USD£5,852GBP
- Report
- July 2024
- 231 Pages
Global
From €2416EUR$2,655USD£2,071GBP
- Report
- June 2023
- 266 Pages
Global
From €3249EUR$3,570USD£2,785GBP
- Report
- October 2023
- 360 Pages
Global
From €3358EUR$3,690USD£2,879GBP
- Report
- September 2022
- 244 Pages
Global
From €3249EUR$3,570USD£2,785GBP

The Transplantation market within the context of Biotechnology is focused on the development of treatments and technologies that enable the successful transfer of organs, tissues, and cells from one individual to another. This includes the development of new methods for organ preservation, the development of new immunosuppressive drugs, and the development of new technologies for organ matching. Additionally, the market is focused on the development of new methods for organ harvesting, as well as the development of new methods for organ transplantation.
The Transplantation market is a rapidly growing sector of the biotechnology industry, with many companies investing in research and development to improve the success rate of organ transplants. Companies in this market include Organogenesis, Organovo, Histogenics, and United Therapeutics. Additionally, many pharmaceutical companies are investing in the development of new immunosuppressive drugs to improve the success rate of organ transplants. Show Less Read more